Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.

Source:http://linkedlifedata.com/resource/pubmed/id/9100552

Download in:

View as

General Info

PMID
9100552